Abstract | PURPOSE OF REVIEW: RECENT FINDINGS: SUMMARY: New oral anticoagulant approval may provide safer and easier venous thromboembolism prevention and treatment than warfarin. As we stand on this threshold, this article reflects on anticoagulation breakthroughs, summarizes recent studies, and discusses potential drawbacks.
|
Authors | Jennifer Carreiro Zikria, Jack Ansell |
Journal | Current opinion in hematology
(Curr Opin Hematol)
Vol. 16
Issue 5
Pg. 347-56
(Sep 2009)
ISSN: 1531-7048 [Electronic] United States |
PMID | 19550318
(Publication Type: Journal Article)
|
Chemical References |
- Anticoagulants
- Factor Xa Inhibitors
- Heparin, Low-Molecular-Weight
- Thrombin
|
Topics |
- Anticoagulants
(chemistry, pharmacology, therapeutic use)
- Factor Xa Inhibitors
- Heparin, Low-Molecular-Weight
(therapeutic use)
- Humans
- Thrombin
(antagonists & inhibitors)
|